当前位置: 首页 > 期刊 > 《中国保健营养·临床医学学刊》 > 2011年第5期 > 正文
编号:12123874
血浆雌激素和一氧化氮相关检验指标对围绝经期女性高血压患者的影响(3)
http://www.100md.com 2011年3月1日 刘颖萍 陈炜 申建民 贾淑琴 靳友华 唐冀兰 唐玲
第1页

    参见附件(3162KB,4页)。

     [6]WuCC,YenMH,Higherlevelofplasmanitricoxideinspontaneouslyhypertensiverats[J].AmJHypertension.1999,12 (5): 476-482.

    [7]MoeKE, Reproductive hormones,aging,and sleep,Semin ReprodEndocrinol.1999,17:339-348.

    [8] Granger J, NovakJ ,Schnackenberg C,et al.Roleofrenalnervesinmediatingthehypertensiveeffectsofnitricoxidesynthesisinhibition [J].Hypertens.1996,27 (3):613-617.

    [9]梁万宁,吴赛珠,刘伊丽,等. 绝经后妇女冠心病患者性激素变化的研究[J].中华心血管病杂志,1998,26(3):181~183,[10]Mosca L ,Collins P, Herrington DM, et al.Homone replacement therapy and cardiovascular disease: a statement for heathcare professionals from the American Heart Association, Circulation2001,104:499-503.

    [11]Gilligan DM, Quyyumi AA, CannonRO.Effcts of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.Circulation, 1994,89(6):2545-2551.

    [12]Cathapermal S, Lavigne MC, Leong-Son M, et al. Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17β-estradiol is estrogen receptor dependent. Joural of Cardiovascular Pharmacology, 1998, 31(4):499~505

    [13]Heikkinen AM, Niskanen L, Yla-Herttuala-S, et al. Postmenop ausal hormone replacement therapy and autoantibodyies against oxidized LDL. Maturitas. 1998 Jun 3;29(2):155~61

    注:本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文

您现在查看是摘要介绍页,详见PDF附件(3162KB,4页)